Table 2.
Clinical measurements |
Total RNA concentration |
% of Detection of transcripts |
||||||||||
ID | Age, y | Weight, kg | BMI | BP s/d | HbA1c | % Fat | Lymph | Musc | Adip | Lymph | Musc | Adip |
A | 34 | 63.7 | 20.3 | 100/70 | 4.8 | 12.20 | 3.96 | 75.27 | 43.82 | 35.2 | 34.6 | 39.9 |
B | 33 | 65.5 | 24.4 | 110/86 | 5.2 | 21.70 | 12.91 | 60.56 | 26.94 | 36.0 | 32.9 | 38.7 |
C | 33 | 105.2 | 35.6 | 136/90 | 5.0 | 38.30 | 14.66 | 158.40 | 52.60 | 35.7 | 34.5 | 35.6 |
D | 37 | 132.2 | 41.3 | 126/90 | 5.4 | 36.30 | 9.89 | 179.00 | 32.64 | 35.8 | 32.8 | 39.2 |
Percentage of body fat mass (Fat, %) was measured by bioimpedance. RNA concentration: μg/mL whole blood (lymphocytes) or ng/mg tissue (muscle and adipose); % detection of transcripts at < 0.05 (see text).
BP s/d, blood pressure systolic/diastolic; HbA1c, hemoglobin A1c; ID, identifier; Lymph, lymphocyte; Musc, muscle; Adip, subcutaneous adipose tissue.